|
|
|
|
|
|
City of Hope is recognized internationally for its breakthrough research discoveries and clinical treatments for lymphoma and related disorders such as leukemia, myeloma and myelodysplastic syndromes. To learn more about any of our primary lymphoma treatment and research staff, click on their name below.
|
|
|
 | Auayporn P. Nademanee, M.D.
Professor and Associate Clinical Director, Hematology & Hematopoietic Cell Transplantation; Director, Matched Unrelated Donor Program
800-826-HOPE (4673)
|
|
 | Joseph C. Alvarnas, M.D.
Director, Quality Systems for Cellular Therapeutics, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
|
 | Ji-Lian Cai, M.D., Ph.D.
Assistant Clinical Professor of Hematology/HCT, City of Hope - Kaiser HCT Program
800-826-HOPE (4673)
|
|
 | Robert W. Chen, M.D.
Staff Physician and Assistant Professor, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
|
| |
| |
| |
|
 | Eileen P. Smith, M.D.
Associate Director, Clinical Research, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
|
|
|
|
|
|
|  |
|
| Advanced Search Options |
| News & Publications Search |
 |
|
|
|
|
|
